Multi Component Detection

Abstract

The disclosure provides methods for detecting the concurrent presence of at least two targets within a biological sample. The method includes contacting said biological sample with a first binding agent, said first binding agent operably linked to a first sortase molecule, wherein said first binding agent specifically binds to a first target; contacting said biological simple with a second binding agent, said second binding agent operably linked to a first sortase recognition sequence peptide, wherein said second binding agent specifically binds to a second target; adding a sortase substrate under conditions where a first sortase-mediated ligation of the sortase substrate to the first sortase recognition sequence will produce a ligation product, and detecting the ligation product, wherein detection of said ligation product indicates the concurrent presence of the first target and the second target in the biological sample. Also disclosed are kits comprising reagents for performing the methods as claimed.

1 . A method for detecting the concurrent presence of at least two targets within a biological sample, comprising:
 (a) contacting said biological sample with a first binding agent, said first binding agent operably linked to a first sortase molecule, wherein said first binding agent specifically binds to a first target;   (b) contacting said biological sample with a second binding agent, said second binding agent operably linked to a first sortase recognition sequence peptide, wherein said second binding agent specifically binds to a second target;   (c) adding a sortase substrate under conditions where a first sortase-mediated ligation of the sortase substrate to the first sortase recognition sequence will produce a ligation product, and   (d) detecting the ligation product, wherein detection of said ligation product indicates the concurrent presence of the first target and the second target in the biological sample.   
     
     
         2 . (canceled) 
     
     
         3 . The method of  claim 1 , wherein the first sortase molecule is a Sortase A molecule. 
     
     
         4 . The method of  claim 3 , wherein the Sortase A molecule is from  Staphylococcus aureus.    
     
     
         5 . The method of  claim 1 , wherein the first sortase recognition sequence peptide comprises the amino acid sequence LPXTG, where X is any amino acid residue (SEQ ID NO: 1). 
     
     
         6 .- 7 . (canceled) 
     
     
         8 . The method of  claim 1 , wherein the sortase substrate comprises the amino acid sequence GGG. 
     
     
         9 . The method of  claim 1 , wherein detecting the ligation product performed using a fourth binding agent that specifically binds to the ligation product. 
     
     
         10 . The method of  claim 9 , wherein the fourth binding agent is detectable. 
     
     
         11 . The method of  claim 1 , wherein the first sortase molecule is directly attached to the first binding agent. 
     
     
         12 . The method of  claim 1 , wherein the first sortase molecule is indirectly attached to the first binding agent. 
     
     
         13 . The method of  claim 1 , wherein the first sortase recognition sequence peptide is directly attached to the second binding agent. 
     
     
         14 . The method of  claim 1 , wherein the first sortase recognition sequence peptide is indirectly attached to the second binding agent. 
     
     
         15 .- 16 . (canceled) 
     
     
         17 . The method of  claim 1 , wherein the first target and the second target are on the same molecule. 
     
     
         18 .- 19 . (canceled) 
     
     
         20 . The method of  claim 1 , wherein the first binding agent is an antibody. 
     
     
         21 . The method of  claim 1 , wherein the second binding agent is an antibody. 
     
     
         22 . (canceled) 
     
     
         23 . The method of  claim 9 , wherein the fourth binding agent is an antibody. 
     
     
         24 . The method of  claim 1 , wherein the biological sample is selected from the group consisting of a cell, a biopsy sample, a blood sample, a tissue sample, a saliva sample, a tear sample, a semen sample, cerebrospinal fluid sample, a bone marrow sample, a bone marrow sample, and a circulating tumor cell sample. 
     
     
         25 . The method of  claim 1 , wherein the biological sample is from a human. 
     
     
         26 . A kit comprising a first sortase recognition sequence directly attached to a first member of a first binding member pair, a first sortase molecule directly attached to a first member of a second binding member pair; a sortase substrate; and instructions for using the kit to detect the concurrent presence of at least two targets within a biological sample. 
     
     
         27 . The kit of  claim 26 , wherein the sortase substrate is directly attached to a first member of a third binding member pair. 
     
     
         28 .- 31 . (canceled)